Tag Search Result

Show result per page
Page 1 of 456

Life & Health tag returned 4557 results

  • China: Shin Kong to inject funds in mainland JV

    The board of directors of Taiwanese life insurer, Shin Kong Life, has approved a proposal to increase the company's investment in Beijing-headquartered Dingcheng Life Insurance by CNY187.5m ($26.3m), according to a filing with the Taiwan Stock Exchange.

    China | 29 May 2020
  • Fanhua says agent recruitment and sales activities resumed in May

    Nasdaq listed Fanhua, a leading independent financial services provider in China,Since the beginning of May, has gradually resumed all kinds of offline training, agent recruitment and sales activities, following a lockdown imposed as the COVID-19 pandemic spread.

    China | 29 May 2020
  • Premier says China has room to stimulate economy, aims for positive growth this year

    China has room to stimulate an economy trying to recover in the wake of the coronavirus pandemic, but the government does not want to open the "floodgates", Premier Li Keqiang said yesterday at the end of the annual meeting of the national parliament, reported Reuters.

    China | 29 May 2020
  • Insurance market shows recovery from COVID-19 impact

    From January to April, the Chinese insurance industry achieved aggregate premiums of CNY1.99tn ($277.8bn), a year-on-year increase of 4.34%. This is an improvement over its performance in the first three months of this year

    China | 29 May 2020
  • Guidelines proposed for insurers' health management services

    The Life Insurance Department of the CBIRC has drafted guidelines relating to the management of health services in insurance companies.

    China | 29 May 2020
  • Insurance sector taps low interest rates in bond issuance spree

    Ten insurance companies have issued capital supplementary bonds this year to date, raising a combined CNY51.95bn ($7.3bn), a figure which exceeds the total amount raised the whole of last year.

    China | 29 May 2020
  • Listed company calls off planned merger with insurer

    Shenzhen listed Hubei Biocause Pharmaceutical has cancelled plans to merge with Guohua Life. Biocause currently hold a 51% stake in Guohua Life. The fundraising exercise to finance the acquisition of the remaining 41% stake was also aborted.

    China | 29 May 2020
  • #MunchwithJenandBen- Ep 11- Ask us anything, finale episode

    The finale of the season #MunchwithJenandBen summed up nicely with an "Ask us anything" segment. Together with co-hosts Jensen Siaw, International Motivational Speaker, Benjamin Ang, Editor and Ken Kish, Owner of Munch Munch, regular featured guest, Coach Joshua Luke joined in the trio for a casual and fun night.

    Agents | 28 May 2020
  • Mental health a first line of defence in coping with pandemic

    Ensuring the mental well-being of its staff has been a key factor in helping AXA navigate through the COVID-19 pandemic, its CEO for Asia Gordon Watson told Asia Insurance Review recently.

    AIRPlus | 28 May 2020
  • GoalsMapper offered a month's free subscription for financial advisers

    Financial advisers in Singapore, Malaysia, and Thailand who were using GoalsMapper benefited from up to a month's free subscription on the platform in April. This initiative costs the GoalsMapper team approximately USD$70,000 in revenue.

    Agents | 27 May 2020

    Follow Asia Insurance Review